secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001437749-23-017581
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology announces results of 2023 annual meeting of stockholders
---------------------------------------------------------------------------

- All eight director nominees elected; highest 'for' vote was Cesano at 30,203,447, lowest was Wilson at 26,825,653.
- KPMG LLP ratified as independent auditor for FY2023 with 39,051,453 votes for, 113,960 against.
- Advisory say-on-pay proposal approved: 28,584,098 for, 2,112,789 against, 113,566 abstain.
- Broker non-votes of 8,447,026 recorded on director election and say-on-pay proposals.
- No other proposals or material business conducted at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/0001437749-23-017581-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774923017581/pbyi20230615_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-017581

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer